Efficacy of Ascorbic Acid on Reducing the Development of Contrast-Induced Nephropathy
Introduction To assess the benefits of prophylactic ascorbic acid to reduce development of contrast-induced nephropathy (CIN) in patients undergoing percutaneous coronary interventions (PCIs). Methods PubMed was searched with the search strategy of (vi...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Razavi Hospital, Mashhad, Iran
2016-11-01
|
Series: | Razavi International Journal of Medicine |
Online Access: | http://dx.doi.org/10.5812/rijm.37341 |